Suzanne Amery

Guy's and St Thomas' NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

7h-index158citations22works1.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(21), Urinary and Genital Oncology Studies(9), Cancer survivorship and care(4), Cancer Research and Treatments(3), Epigenetics and DNA Methylation(2)

Publications22 total

Survival Outcomes of BCG Only, BCG Plus EMDA-MMC or Upfront Radical Cystectomy in High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): A Multicentre, International, Collaborative Study from Tertiary Referral Institutions
Cancers·2026Open Access
Delayed vs. Concomitant Urethrectomy for Non-Metastatic Urothelial Carcinoma of the Urinary Bladder Undergoing Radical Cystectomy: Perioperative and Survival Outcomes from a Single Tertiary Centre in the United Kingdom
Journal of Personalized Medicine·2025· 1 citedOpen Access
Contemporary Trends and Predictors Associated with Adverse Pathological Upstaging Among Non-Metastatic Localized Clinical T2 Muscle-Invasive Bladder Cancers Undergoing Radical Cystectomy: Outcomes from a Single Tertiary Centre in the United Kingdom
Cancers·2025· 2 citedOpen Access
P238 Intravesical treatment in patients with high risk non-muscle invasive bladder cancercan treatment with sequential bacillus calmette-guérin/electromotive drug administration of mitomycin c delay or even prevent it?
European Urology Open Science·2024Open Access
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
BJUI Compass·2024· 7 citedOpen Access
A cohort profile of the Graham Roberts study cohort
Frontiers in Oncology·2024Open Access
Is there a role for physical activity interventions in the treatment pathway of bladder cancer? A scoping review of the literature
BMJ Open Sport & Exercise Medicine·2021· 7 citedOpen Access
The need for supportive mental wellbeing interventions in bladder cancer patients: A systematic review of the literature
PLoS ONE·2021· 14 citedOpen Access
Designing a Pragmatic Intervention to Help Improve the Bladder Cancer Patient Experience
INQUIRY The Journal of Health Care Organization Provision and Financing·2021· 2 citedOpen Access
Understanding the bladder cancer patients experience: What are the needs?
European Urology Open Science·2020Open Access
Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence
BMC Urology·2020· 41 citedOpen Access
Graham Roberts Study protocol: first ‘trials within cohort study’ for bladder cancer
BMJ Open·2019· 8 citedOpen Access
Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method
European Urology·2019· 35 citedOpen Access
Will long-term disease specific outcomes of bladder conservation with sequential Bacillus Calmette-Guérin (BCG) and electromotive drug administration Mitomycin-C (EMDA-MMC) for high-risk non-muscle invasive bladder cancer (HR-NMIBC) influence adoption?
Frontiers in Oncology·2019Open Access
PD19-06 HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (HR-NMIBC) TREATED WITH SEQUENTIAL BCG / ELECTROMOTIVE DRUG ADMINISTRATION MITOMYCIN-C (EMDA-MMC): 2% DISEASE-SPECIFIC MORTALITY AT 4 YEARS' FOLLOW-UP
The Journal of Urology·2017
Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes
The Journal of Urology·2016· 37 cited
Poster Sessions
British Journal of Urology·2014Open Access
1000 Long term follow up of a prospective randomised trial of Hexylaminolevulinate (HEXVIX ®) photodynamic diagnosis (PDD) assisted versus conventional white-light transurethral resection (TURBT) in newly presenting non-muscle invasive bladder cancer (NMIBC)
European Urology Supplements·2014· 1 cited
MP56-15 SEQUENTIAL BCG / ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) MITOMYCIN C (MMC) AS THE STANDARD INTRAVESICAL REGIMEN IN HIGH RISK NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) – ONE YEAR OUTCOMES
The Journal of Urology·2014· 1 cited
MP22-08 LONG TERM FOLLOW UP OF A PROSPECTIVE RANDOMISED TRIAL OF HEXYLAMINOLEVULINATE (HEXVIX®) PHOTODYNAMIC DIAGNOSIS (PDD) ASSISTED VERSUS CONVENTIONAL WHITE-LIGHT TRANSURETHRAL RESECTION (TURBT) IN NEWLY PRESENTING NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
The Journal of Urology·2014· 2 cited
page 1 of 2Next →

Frequent Co-authors

Kathryn Chatterton(22), Muhammad Shamim Khan(13), Ramesh Thurairaja(10), Mieke Van Hemelrijck(9), Deborah Enting(8), Rajesh Nair(8), Christel Häggström(6), Fidelma Cahill(6), Harriet Wylie(6), Christine Gan(6), Kay Thomas(6), Agustina Bessa(5), Sachin Malde(5), Richard T. Bryan(5), Charlotte Moss(5), Anna Haire(4), Simon Hughes(4), Beth Russell(4), Shamim Khan(4), Margaret Northover(3)